Sangamo Therapeutics
SGMO
#9117
Rank
โ‚น11.24 B
Marketcap
โ‚น30.26
Share price
-6.74%
Change (1 day)
-58.94%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -โ‚น9.46 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚น32.87 Million. In 2024 the company made an earning of -โ‚น9.29 Billion, an increase over its 2023 earnings that were of -โ‚น11.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น9.46 Billion1.79%
2024 -โ‚น9.29 Billion-17.27%
2023 -โ‚น11.23 Billion-40.88%
2022 -โ‚น18.99 Billion9.79%
2021 -โ‚น17.3 Billion41.52%
2020 -โ‚น12.22 Billion23.17%
2019 -โ‚น9.92 Billion36.33%
2018 -โ‚น7.28 Billion36.89%
2017 -โ‚น5.32 Billion-22.32%
2016 -โ‚น6.85 Billion54.86%
2015 -โ‚น4.42 Billion75.62%
2014 -โ‚น2.52 Billion0.13%
2013 -โ‚น2.52 Billion
2011 -โ‚น3.38 Billion43.66%
2010 -โ‚น2.36 Billion28.52%
2009 -โ‚น1.83 Billion-23.55%
2008 -โ‚น2.4 Billion2.45%
2007 -โ‚น2.34 Billion19.5%
2006 -โ‚น1.96 Billion50.78%
2005 -โ‚น1.3 Billion75%
2004 -โ‚น0.75 Billion-33.25%
2003 -โ‚น1.11 Billion-62.27%
2002 -โ‚น2.95 Billion102.82%
2001 -โ‚น1.46 Billion23.21%
2000 -โ‚น1.18 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น3.164 T-30,874.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น846.52 B-8,332.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น146.79 B-1,527.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-โ‚น236.82 Billion 2,203.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น923.95 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.114 T-20,666.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น54.30 B-628.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น45.50 B-542.54%๐Ÿ‡บ๐Ÿ‡ธ USA